Health & Medicine
-
New Drug Forces Immune Cells to Attack Multiple Myeloma
August 15, 2023, brought a significant shift for multiple myeloma patients who had exhausted existing therapies. On that date, regulatory authorities in…
-
Talquetamab approved for multiple myeloma in US and EU
United States, August 16, 2023 — cybernewschronicle.com — On August 15, 2023, the medical community marked a significant milestone with the approval…
-
Experimental Medication AOH1996 Enters Phase I Cancer Treatment Trials
An investigational cancer medication called AOH1996 has entered Phase I clinical trials at City of Hope as of August 15, 2023, marking…
-
City of Hope drug targets cancer-specific protein, spares healthy cells
/ HTML. 450-560 words. Must not invent quotes etc. Use only facts from source. Let’s list facts: – DNA repair mechanics frustrated…
-
FDA Approves Cancer Drug That Forces Immune Cells to Attack Tumors
/ HTML. So we need headings maybe and paragraphs . Must not add any extra info. Must keep facts: FDA approved Elranatamab…
-
Arizona Hospitals Surge as Heat Emergency Declared
Arizona, August 11, 2023 — infopulsetoday.com — Arizona’s emergency rooms are seeing a surge in heat-related cases as the state weathers a…
-
WHO Flags BA.2.86 COVID Variant with 30 Spike Mutations
July 30, 2023 — cybernewschronicle.com — The detection of BA.2.86 on July 24, 2023, is not simply another entry in the long…
-
BA.2.86 heavily-mutated Omicron subvariant sparks global health concern
A new subvariant of the SARS-CoV-2 virus, known as BA.2.86, has been detected, sparking concern among health experts due to its significant…
-
South African variant: Beta strain B.1.351 impact on COVID-19 immunity
The South African variant refers to several variants of SARS-CoV-2, a virus that has been closely monitored globally due to its potential…
-
South Africa Leads Global Detection Of New Coronavirus Variants Emerge
Since the pandemic began, South African laboratories have repeatedly emerged as the first point of discovery for SARS‑CoV‑2 lineages that later achieved…
-
Global Liver Associations Adopt New Disease Naming Convention Effective Immediately
Under a novel nomenclature agreed upon by three prominent global liver organizations, a prevalent liver ailment is set to undergo a significant…
-
Fatty liver disease: New classification and understanding as of June 2023
Fatty liver disease (FLD), a condition characterized by the buildup of excess fat in the liver, has been a subject of increasing…
-
Breakthrough in Synthetic Embryo Research Offers New Miscarriage Insights
In the United States, tens of thousands of pregnancies end in miscarriage each year, yet the underlying causes often remain unknown. While…
-
Swiss Brain Implants Let Paralyzed Man Walk Naturally
A groundbreaking medical breakthrough has been achieved by Swiss scientists, who have successfully enabled a paralyzed man to walk naturally through the…
-
New Treatment Approved for Aggressive Blood Cancer Patients Nationwide
Diffuse large B‑cell lymphoma progresses rapidly and can infiltrate lymph nodes, spleen, liver, and bone marrow. For many patients whose disease returns…
-
Epcoritamab approved in US for large B-cell lymphoma
United States, May 22, 2023 — cybernewschronicle.com — Epcoritamab, a novel Bi-specific T-cell engager (BiTE) therapy, has marked a significant milestone in…
-
Mutated Enzyme Becomes Target for Cancer Drug Ivosidenib
A medication now in its fifth year of clinical use works by targeting a single altered enzyme present in some patients with…
-
Ivosidenib Hits FDA Milestone for AML and Cholangiocarcinoma
Ivosidenib, marketed under the brand name Tibsovo, has marked a significant milestone in the treatment of certain types of cancer, including acute…
-
COVID-19 global health emergency ends as WHO declares pandemic over in May 2023
As of May 15, 2023, the World Health Organization has declared the end of the COVID-19 global health emergency, which was initially…
-
WHO Formally Ends Global COVID-19 Emergency Status After Three Years
The World Health Organization has officially ended the global emergency status for COVID-19, marking a formal conclusion to a crisis that began…
-
Pfizer’s Paxlovid Cuts COVID Hospitalization Risk by 88%
A recent analysis of Pfizer’s oral antiviral Paxlovid indicates that it can lower the chance of hospitalization or death by 88% among…
-
WHO Ends COVID-19 Emergency Status Amid Lingering Health Concerns
The World Health Organization ended COVID-19’s global health emergency designation on May 15, 2023, but this official step does not mark the…
-
Paxlovid Cuts COVID Hospitalization Risk by 88%
Nirmatrelvir/ritonavir, a co-packaged medication sold under the brand name Paxlovid, has been making headlines as a treatment for COVID-19. Developed by Pfizer,…
-
WHO Lifts COVID-19 Global Emergency After 3 Years
Wuhan, China, May 5, 2023 — cybernewschronicle.com — The end of a global public health emergency is not the end of a…
Most read
-
Minnesota Makes Personal Finance Course Mandatory for High School Graduation
-
UK Households With £10,000 Risk Losing £300 To Low Interest Rates
-
Selangor International Care Expo in Kuala Lumpur 2026
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Sugar‑sweetened beverages raise teen anxiety and depression risk, Australian study finds
-
How Liquid Biopsy Is Transforming Cancer Monitoring and Early Detection Strategies
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
MD Anderson Breakthroughs Advance Immunotherapy for Lung Cancer
-
How Modern Immunotherapy Is Redefining Cancer Treatment Beyond Chemotherapy
-
26% of Americans Spend More Than They Earn as Credit Card Debt Rises and Budgets Tighten
-
How Medicaid Estate Recovery Claims Decedents’ Homes Through Premiums
-
How Insurance Agent Commissions Drive Medicare Advantage Enrollments
-
How Medicare Advantage Plans Hide the 63-Day Medigap Window—and What It Costs You to Miss It
-
How Mortgage Rates Could Shift Over the Next Five Years
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Dennis Lo Pioneers Liquid Biopsy for Cancer and Prenatal Testing
-
Theo Burrell’s death sparks renewed calls for brain cancer research funding
-
Thousands embrace mud and purpose at Heaton Park Pretty Muddy run.
-
Study Links Lung Tumor Mutation, High-Fat Diet, and Nerve Pathway to Wasting Syndrome
-
New Research Highlights Rising Internet Addiction Debate
-
Study Suggests Drinking Water With Meals May Lead To Overeating
-
Real-World Oncotype DX Adoption: Rates and Key Challenges
-
Energy Drinks: Youth Marketing, Caffeine Risks Under Scrutiny
-
ADHD Dopamine Dysfunction Disrupts Sleep-Wake Cycles, Study Finds
























